FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to new compounds of formula I 
, where: R1, R2, R3 and R4 independently from each other mean hydrogen, F, CI, Br, I; R5 designates hydrogen, alkyl with 1, 2, 3, 4, 5 or 6 C atoms, or cycloalkyl with 3, 4, 5 or 6 C atoms; R6 designates hydrogen; R7 and R8 independently from each other mean hydrogen, W means CrH2r or CsH2S-2; and one or more CH2-groups in C2H2r and CsH2s-2 can be substituted with NR17, oxygen or S; R17 means hydrogen, alkyl with 1, 2, 3 or 4 C atoms; r means 1, 2, 3, 4, 5 or 6; s means 2, 3 or 4; X designates-with C(O)- or -S(O)2-; Z means -C(O)- or a bond; and also to their pharmaceutically acceptable salts and trifluoroacetates. The invention also concerns application of the compounds of formula I, and also to a pharmaceutical composition.
EFFECT: preparation of new biologically active compounds exhibiting NHE3 inhibiting activity.
16 cl, 64 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| SUBSTITUTED 4-PHENYLTETRAHYDROISOQUINOLINE, THEIR USING AS MEDICINAL AGENT AND MEDICINAL AGENT COMPRISING THEREOF | 2002 |
|
RU2298003C2 |
| SUBSTITUTED 4-PHENYLTETRAHYDROISOQUINOLINES, METHOD OF THEIR OBTAINING, THEIR APPLICATION AS MEDICATIONS, AND MEDICATIONS CONTAINING THEM | 2004 |
|
RU2343147C2 |
| SUBSTITUTED AMINOINDANS AND ANALOGUES THEREOF TO BE USED IN PHARMACEUTICS | 2009 |
|
RU2522586C2 |
| SUBSTITUTED THIOPENES, THEIR USING AS MEDICINAL OR DIAGNOSTIC AGENT AND MEDICINAL AGENT COMPRISING THEREOF | 2003 |
|
RU2315766C2 |
| PYRAZOLOPYRIMIDINES AND RELATED HETEROCYCLES AS CK2 INHIBITORS | 2010 |
|
RU2607453C2 |
| NEW AMIDE DERIVATIVES AND USING THEM AS MEDICINAL PRODUCT | 2011 |
|
RU2574409C2 |
| NEW IMIDE DERIVATIVES AND THEIR USE AS DRUG | 2016 |
|
RU2772429C2 |
| MEDICINAL COMPOUNDS | 2014 |
|
RU2691105C1 |
| COMPOUNDS AND METHODS FOR INHIBITING NHE-MEDIATED ANTIPORT IN THE TREATMENT OF DISORDERS ASSOCIATED WITH FLUID RETENTION OR SALT OVERLOAD AND GASTROINTESTINAL DISEASES | 2013 |
|
RU2684097C2 |
| NEW PHENYLAMIDE OR PYRIDYLAMIDE DERIVATIVES AND USING THEM AS GPBAR1 AGONISTS | 2009 |
|
RU2533887C2 |
